US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 47.910
  • -2.520-5.00%
Close Feb 21 16:00 ET
  • 47.670
  • -0.240-0.50%
Post 20:01 ET
4.11BMarket Cap-11.04P/E (TTM)

About CRISPR Therapeutics Company

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Company Profile

SymbolCRSP
Company NameCRISPR Therapeutics
Listing DateOct 19, 2016
Issue Price14.00
Founded2013
CEODr. Samarth Kulkarni, PhD
MarketNASDAQ
Employees393
Fiscal Year Ends12-31
AddressBaarerstrasse 14
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-41-561-32-77

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board and Chief Executive Officer
  • 12.32M
  • Julianne Bruno
  • Chief Operating Officer
  • --
  • Dr. Raju Prasad
  • Chief Financial Officer and Principal Accounting Officer
  • 5.72M
  • Dr. H. Edward Fleming, M.D.
  • Independent Director
  • 536.24K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 545.06K
  • Dr. Simeon J. George, M.B.A.,M.D.
  • Independent Director
  • 542.56K
  • Dr. Douglas A. Treco, PhD
  • Lead Independent Director
  • 552.56K
  • Sandesh Mahatme, L.L.M.
  • Independent Director
  • --
  • Dr. Maria Fardis, PhD
  • Independent Director
  • 532.84K
  • John T. Greene
  • Independent Director
  • 555.06K
  • Dr. Christian Rommel, PhD
  • Independent Director
  • --
  • Dr. Katherine A. High, M.D.
  • Independent Director
  • 532.56K
  • James R. Kasinger
  • General Counsel and Secretary
  • 3.51M

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More